Changing Provider Behavior in the Context of Chronic Disease Management: Focus on Clinical Inertia

被引:43
作者
Lavoie, Kim L. [1 ,2 ]
Rash, Joshua A. [3 ]
Campbell, Tavis S. [3 ]
机构
[1] Univ Quebec Montreal UQAM, Dept Psychol, Montreal, PQ H3C 3P8, Canada
[2] Hop Sacre Coeur Montreal, Res Ctr, MBMC, Montreal, PQ H2J 1C5, Canada
[3] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada
来源
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 57 | 2017年 / 57卷
关键词
clinical inertia; therapeutic inertia; diagnostic inertia; clinical practice guidelines; evidence-based medicine; DECISION-SUPPORT-SYSTEMS; EVIDENCE BASED MEDICINE; PRIMARY-CARE PHYSICIANS; BLOOD-PRESSURE; HEALTH-CARE; HYPERTENSION TREATMENT; THERAPEUTIC INERTIA; DIABETES-MELLITUS; QUALITY IMPROVEMENT; PRACTICE GUIDELINES;
D O I
10.1146/annurev-pharmtox-010716-104952
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Widespread acceptance of evidence-based medicine has led to the proliferation of clinical practice guidelines as the primary mode of communicating current best practices across a range of chronic diseases. Despite overwhelming evidence supporting the benefits of their use, there is a long history of poor uptake by providers. Nonadherence to clinical practice guidelines is referred to as clinical inertia and represents provider failure to initiate or intensify treatment despite a clear indication to do so. Here we review evidence for the ubiquity of clinical inertia across a variety of chronic health conditions, as well as the organizational and system, patient, and provider factors that serve to maintain it. Limitations are highlighted in the emerging literature examining interventions to reduce clinical inertia. An evidence-based framework to address these limitations is proposed that uses behavior change theory and advocates for shared decision making and enhanced guideline development and dissemination.
引用
收藏
页码:263 / 283
页数:21
相关论文
共 112 条
  • [1] THE THEORY OF PLANNED BEHAVIOR
    AJZEN, I
    [J]. ORGANIZATIONAL BEHAVIOR AND HUMAN DECISION PROCESSES, 1991, 50 (02) : 179 - 211
  • [2] Nonadherence, Clinical Inertia, or Therapeutic Inertia?
    Allen, J. Daniel
    Curtiss, Frederic R.
    Fairman, Kathleen A.
    [J]. JOURNAL OF MANAGED CARE PHARMACY, 2009, 15 (08): : 690 - 695
  • [3] [Anonymous], 2013, Bmj, DOI DOI 10.1136/BMJ.F657
  • [4] [Anonymous], COCHRANE DATABASE SY
  • [5] [Anonymous], 2016, GLOB STRAT DIAGN MAN
  • [6] The economic and clinical benefits of adequate insulin initiation and intensification in people with type 2 diabetes mellitus
    Asche, C. V.
    Bode, B.
    Busk, A. K.
    Nair, S. R.
    [J]. DIABETES OBESITY & METABOLISM, 2012, 14 (01) : 47 - 57
  • [7] Factors associated with clinical inertia: an integrative review
    Aujoulat, Isabelle
    Jacquemin, Patricia
    Rietzschel, Ernst
    Scheen, Andre
    Trefois, Patrick
    Wens, Johan
    Darras, Elisabeth
    Hermans, Michel P.
    [J]. ADVANCES IN MEDICAL EDUCATION AND PRACTICE, 2014, 5 : 141 - 147
  • [8] Balder JW, 2015, NETH J MED, V73, P316
  • [9] Bandura A., 1986, Social foundations of thought and action: a social cognitive theory, P23
  • [10] Barr R Graham, 2005, Am J Med, V118, P1415